Skip to content

Clinical trials

Not yet recruiting Triple Negative Breast Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Not yet recruiting Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20244
20255
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University5
Tianjin Medical University Cancer Institute and Hospital3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
GV20 Therapeutics1
Harbin Medical University1
Mabwell (Shanghai) Bioscience Co., Ltd.1
Shanghai Henlius Biotech1
Shanghai Junshi Bioscience Co., Ltd.1
Shengjing Hospital1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms19
Breast Neoplasms5
Colorectal Neoplasms2
Small Cell Lung Carcinoma2
Uterine Cervical Neoplasms2
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Cholangiocarcinoma1
Esophageal Squamous Cell Carcinoma1
Gallbladder Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.